Using various techniques, we demonstrated the expression of both FOXP3 mRNA and protein in purified CLL B cells after exclusion of any Tregs or other immune cells, and using FOXP3-positive cells such as Tregs and CD4+ T cells as a control. The gene discussed is FOXP3; the disease is B-cell chronic lymphocytic leukemia.